Stakeholder research priorities for smoking cessation interventions within lung cancer screening programs an official American thoracic society research statement

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 9, 2017, Pages 1202-1212

  Kathuria, Hasmeena ^a   Detterbeck, Frank C ^a   Fathi, Joelle T ^a   Fennig, Kathleen ^a   Gould, Michael K ^a   Jolicoeur, Denise G ^a   Land, Stephanie R ^a   Massetti, Greta M ^a   Mazzone, Peter J ^a   Silvestri, Gerard A ^a   Slatore, Christopher G ^a   Smith, Robert A ^a   Vachani, Anil ^a   Zeliadt, Steven B ^a   Wiener, Renda Soylemez ^a  

^a Pulmonary Center   (United States)

Author keywords

LDCT screening; Lung cancer screening; Research priorities; Smoking cessation; Tobacco dependence treatment

Indexed keywords

ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED PRACTICE; HEALTH SURVEY; HUMAN; LOW DOSE COMPUTED TOMOGRAPHY; LUNG CANCER; OUTCOME ASSESSMENT; POPULATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING TEST; SMOKING CESSATION; TOBACCO DEPENDENCE; COMPLICATION; LUNG TUMOR; MASS SCREENING; MEDICAL RESEARCH; MEDICAL SOCIETY; PROCEDURES; UNITED STATES;

BIOMEDICAL RESEARCH; HUMANS; LUNG NEOPLASMS; MASS SCREENING; SMOKING CESSATION; SOCIETIES, MEDICAL; TOBACCO USE DISORDER; UNITED STATES;

EID: 85032663845     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201709-1858ST     Document Type: Article

References (55)

1. American Cancer Society. Cancer facts and figures 2016. Atlanta, GA: American Cancer Society; 2016.
2. U.S. Cancer Statistics Working Group, CDC. United States cancer statistics: 1999-2013 incidence and mortality web-based report. Atlanta, GA: Department of Health and Human Services, CDC, and National Cancer Institute; 2016 [accessed 2017 May 11]. Available from: http://www.cdc.gov/uscs
3. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100E: A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012;100(Pt E):1-538.
4. U.S. Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon General, 2014 [accessed 2017 May 11]. Available from: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html
5. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current Cigarette Smoking Among Adults-United States, 2005-2015. MMWR Morb Mortal Wkly Rep 2016; 65:1205-1211.
6. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, McAfee T, Peto R. 21st-Century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368:341-350.
7. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2016;(5):CD006103.
8. Woloshin S, Schwartz LM, Welch HG. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst 2008;100:845-853.
9. Hays JT, Ebbert JO, Sood A. Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline. Mayo Clin Proc 2009;84:730-735, quiz 735-736.
10. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults-United States, 2000-2015. MMWR Morb Mortal Wkly Rep 2017;65:1457-1464.
11. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365:395-409.
12. Black WC. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis. J Thorac Imaging 2015;30:79-87.
13. Tanner NT, Gebregziabher M, Hughes Halbert C, Payne E, Egede LE, Silvestri GA. Racial differences in outcomes within the National Lung Screening Trial: implications for widespread implementation. Am J Respir Crit Care Med 2015;192:200-208.
14. Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, et al.; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med 2015;192:881-891.
15. Fucito LM, Czabafy S, Hendricks PS, Kotsen C, Richardson D, Toll BA; Association for the Treatment of Tobacco Use and Dependence/Society for Research on Nicotine and Tobacco Synergy Committee. Pairing smoking-cessation services with lung cancer screening: a clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016;122:1150-1159.
16. Land SR, Marcus PM. Cancer screening and diagnosis: opportunities for smoking cessation intervention. J Clin Oncol 2015;33: 1631-1632.
17. National Academies of Sciences, Engineering, and Medicine. Implementation of lung cancer screening: proceedings of a workshop. Washington, DC: The National Academies Press; 2017.
18. Cox LS, Okuyemi K, Choi WS, Ahluwalia JS. A review of tobacco use treatments in U.S. ethnic minority populations. Am J Health Promot 2011;25(5 Suppl):S11-S30.
19. Murray RP, Connett JE, Buist AS, Gerald LB, Eichenhorn MS. Experience of black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tob Res 2001;3:375-382.
20. Lee CS, Hayes RB, McQuaid EL, Borrelli B. Predictors of retention in smoking cessation treatment among Latino smokers in the Northeast United States. Health Educ Res 2010;25:687-697.
21. McBride CM, Ostroff JS. Teachable moments for promoting smoking cessation: the context of cancer care and survivorship. Cancer Contr 2003;10:325-333.
22. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003;18:156-170.
23. Ashraf H, Tønnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Døssing M. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax 2009;64:388-392.
24. Ashraf H, Saghir Z, Dirksen A, Pedersen JH, Thomsen LH, Døssing M, Tønnesen P. Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme. Thorax 2014;69:574-579.
25. Park ER, Gareen IF, Japuntich S, Lennes I, Hyland K, DeMello S, Sicks JD, Rigotti NA. Primary care provider-delivered smoking cessation interventions and smoking cessation among participants in the National Lung Screening Trial. JAMA Intern Med 2015;175: 1509-1516.
26. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009;338:b1024.
27. Slatore CG, Baumann C, Pappas M, Humphrey LL. Smoking behaviors among patients receiving computed tomography for lung cancer screening: systematic review in support of the U.S. Preventive Services Task Force. Ann Am Thorac Soc 2014;11:619-627.
28. Pedersen JH, Tønnesen P, Ashraf H. Smoking cessation and lung cancer screening. Ann Transl Med 2016;4:157.
29. Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL. Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomarkers Prev 2009;18: 3484-3489.
30. Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA. 'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect 2015;18:355-365.
31. Zeliadt SB, Heffner JL, Sayre G, Klein DE, Simons C, Williams J, Reinke LF, Au DH. Attitudes and perceptions about smoking cessation in the context of lung cancer screening. JAMA Intern Med 2015;175:1530-1537.
32. Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 2015; 162:485-491.
33. McKee BJ, Regis SM, McKee AB, Flacke S, Wald C. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol 2015;12:273-276.
34. Bade M, Bahr V, Brandt U, Eigentopf A, Bruchert T, Gross ML, Motsch E, Becker N. Effect of smoking cessation counseling within a randomised study on early detection of lung cancer in Germany. J Cancer Res Clin Oncol 2016;142:959-968.
35. Marshall HM, Courtney DA, Passmore LH, McCaul EM, Yang IA, Bowman RV, Fong KM. Brief tailored smoking cessation counseling in a lung cancer screening population is feasible: a pilot randomized controlled trial. Nicotine Tob Res 2016;18:1665-1669.
36. Luh DL, Chen SL, Yen AM, Chiu SY, Fann CY, Chen HH. Effectiveness of advice from physician and nurse on smoking cessation stage in Taiwanese male smokers attending a community-based integrated screening program. Tob Induc Dis 2016;14:15.
37. Ferketich AK, Otterson GA, King M, Hall N, Browning KK, Wewers ME. A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer 2012;76:211-215.
38. van der Aalst CM, de Koning HJ, van den Bergh KA, Willemsen MC, van Klaveren RJ. The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer 2012;76:204-210.
39. Clark MM, Cox LS, Jett JR, Patten CA, Schroeder DR, Nirelli LM, Vickers K, Hurt RD, Swensen SJ. Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer 2004;44:13-21.
40. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e78S-e92S.
41. Moyer VA; U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-338.
42. Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI. Readiness of lung cancer screening sites to deliver smoking cessation treatment: current practices, organizational priority, and perceived barriers. Nicotine Tob Res 2016;18:1067-1075.
43. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002;4:149-159.
44. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100:299-303.
45. National Cancer Institute, Division of Cancer Control and Population Sciences. Tobacco use and cessation in cancer screening, diagnosis, treatment, and survivorship [accessed 2017 May 14]. Available from: https://cancercontrol.cancer.gov/brp/tcrb/research-topic-tobacco-use.html
46. Kessler RC. Kessler psychological distress scale [accessed 2017 May 14]. Available from: http://www.integration.samhsa.gov/images/res/K6%20Questions.pdf
47. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-1127.
48. Apodaca TR, Abrantes AM, Strong DR, Ramsey SE, Brown RA. Readiness to change smoking behavior in adolescents with psychiatric disorders. Addict Behav 2007;32:1119-1130.
49. Latimer-Cheung AE, Fucito LM, Carlin-Menter S, Rodriguez J, Raymond L, Salovey P, Makuch R, Cummings KM, Toll BA. How do perceptions about cessation outcomes moderate the effectiveness of a gain-framed smoking cessation telephone counseling intervention? J Health Commun 2012;17:1081-1098.
50. 2015 National Health Interview Survey (NHIS) Questionnaire-Sample Adult Tobacco Document [2016 May 27; accessed 2017 Oct 7]. Available from: https://www.cdc.gov/nchs/nhis/tobacco/tobacco-questions.htm
51. PhenX Toolkit. Research Triangle Park, NC: PhenX Project Communications [accessed 2017 June 15]. Available from: https://www.phenxtoolkit.org/
52. Carson SS, Goss CH, Patel SR, Anzueto A, Au DH, Elborn S, Gerald JK, Gerald LB, Kahn JM, Malhotra A, et al.; American Thoracic Society Comparative Effectiveness Research Working Group. An official American Thoracic Society research statement: comparative effectiveness research in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med 2013;188: 1253-1261.
53. U.S. Department of Health and Human Services. Smoking cessation within the context of lung cancer screening (R01) [accessed 2017 June 26]. Available from: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-011.html
54. Benowitz NL, Hukkanen J, Jacob P III. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009; (192):29-60.
55. Schick SF, Blount BC, Jacob P Rd, Saliba NA, Bernert JT, El Hellani, Jatlow O, Pappas RS, Wang L, Foulds J, et al. Biomarkers of exposure to new and emerging tobacco delivery products. Am J Physiol Lung Cell Mol Physiol 2017;313:L425-L52.